{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T14:19:23Z","timestamp":1795097963858,"version":"4.10.3"},"reference-count":33,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"accepted":{"date-parts":[[2026,6,17]]},"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1136\/archdischild-2025-329987","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:20:16Z","timestamp":1782753616000},"page":"1112-1118","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of antenatal biological response modifying drugs on infant infection risk and vaccination rates: a national cohort study"],"prefix":"10.1136","volume":"111","author":[{"given":"Yoav","family":"Kalron","sequence":"first","affiliation":[{"name":"Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, South District, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7372-6262","authenticated-orcid":false,"given":"Guy","family":"Hazan","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, South District, Israel"},{"name":"Pediatric Pulmonary Unit, Saban Children Hospital, Soroka Medical Center, Beer-Sheva, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8746-1410","authenticated-orcid":false,"given":"David","family":"Greenberg","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, South District, Israel"},{"name":"Pediatric Infectious Diseases Unit, Saban Children Hospital, Soroka Medical Center, Beer Sheva, South District, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5233-1213","authenticated-orcid":false,"given":"Ilan","family":"Youngster","sequence":"additional","affiliation":[{"name":"Paediatric Infectious Diseases, Yitzhak Shamir Medical Center, Zerifin, Israel"},{"name":"Tel Aviv University Faculty of Medical and Health Sciences, Tel Aviv-Yafo, Tel Aviv District, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4819-3871","authenticated-orcid":false,"given":"Dana","family":"Danino","sequence":"additional","affiliation":[{"name":"Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, South District, Israel"},{"name":"Pediatric Infectious Diseases Unit, Saban Children Hospital, Soroka Medical Center, Beer Sheva, South District, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"2026111902151254000_111.12.1112.1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000535647","article-title":"Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy","volume":"42","author":"Sokic-Milutinovic","year":"2024","journal-title":"Dig Dis"},{"key":"2026111902151254000_111.12.1112.2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cgh.2020.09.021","article-title":"Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis","volume":"20","author":"Nielsen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026111902151254000_111.12.1112.3","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/j.jaip.2022.08.013","article-title":"Safety of Biologics for Atopic Diseases During Pregnancy","volume":"10","author":"Shakuntulla","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026111902151254000_111.12.1112.4","doi-asserted-by":"crossref","first-page":"101665","DOI":"10.1016\/j.bpg.2019.101665","article-title":"Effect of biologicals and JAK inhibitors during pregnancy on health-related outcomes in children of women with inflammatory bowel disease","volume":"4445","author":"Wieringa","year":"2020","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2026111902151254000_111.12.1112.5","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2665-9913(24)00096-1","article-title":"The outcomes of children born to mothers with autoimmune rheumatic diseases","volume":"6","author":"Andreoli","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"2026111902151254000_111.12.1112.6","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208840"},{"key":"2026111902151254000_111.12.1112.7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MIB.0000000000000596","article-title":"Use of Immunomodulators and Biologics Before, During, and After Pregnancy","volume":"22","author":"McConnell","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"2026111902151254000_111.12.1112.8","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2023.38.e172","article-title":"Pregnancy Outcomes Associated With Biologic Agent Exposure in Patients With Several Rheumatic Diseases and Inflammatory Bowel Diseases","volume":"38","author":"Ahn","year":"2023","journal-title":"J Korean Med Sci"},{"key":"2026111902151254000_111.12.1112.9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40259-022-00564-4","article-title":"Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase)","volume":"37","author":"Dernoncourt","year":"2023","journal-title":"BioDrugs"},{"key":"2026111902151254000_111.12.1112.10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023714","article-title":"Use of biologics during pregnancy and risk of serious infections in the mother and baby: a Canadian population-based cohort study","volume":"9","author":"Tsao","year":"2019","journal-title":"BMJ Open"},{"key":"2026111902151254000_111.12.1112.11","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1111\/jcpt.13817","article-title":"Management of biologics in pregnant, lactating patients with inflammatory bowel disease and the impact on neonatal vaccination: A systematic review of clinical practice guidelines and consensus statements","volume":"47","author":"Ding","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"2026111902151254000_111.12.1112.12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/ibd\/izy294","article-title":"Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation","volume":"25","author":"Duricova","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"2026111902151254000_111.12.1112.13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bpobgyn.2019.11.003","article-title":"Long-term outcome of children born from mothers with autoimmune diseases","volume":"64","author":"Nalli","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2026111902151254000_111.12.1112.14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5217\/ir.2018.00071","article-title":"Influence of anti-tumor necrosis factor-alpha therapy to pregnant inflammatory bowel disease women and their childrens immunity","volume":"17","author":"Lee","year":"2019","journal-title":"Intest Res"},{"key":"2026111902151254000_111.12.1112.15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.12.022"},{"key":"2026111902151254000_111.12.1112.16","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.12.003"},{"key":"2026111902151254000_111.12.1112.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.02.023"},{"key":"2026111902151254000_111.12.1112.18","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-020-00905-8","article-title":"Vaccination for Children on Biologics","volume":"22","author":"Toplak","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"2026111902151254000_111.12.1112.19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cgh.2017.08.041","article-title":"Use of Biologic Therapy by Pregnant Women With Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines","volume":"16","author":"Beaulieu","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026111902151254000_111.12.1112.20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev404"},{"key":"2026111902151254000_111.12.1112.21","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.04.002"},{"key":"2026111902151254000_111.12.1112.22","doi-asserted-by":"crossref","unstructured":"Kimberlin D . Rotavirus infections. In: Red Book: 20242027 Report of the Committee on Infectious Diseases. Pediatrics AAo, 2024.","DOI":"10.1542\/9781610027373"},{"key":"2026111902151254000_111.12.1112.23","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-056021","article-title":"Safety of Live-Attenuated Vaccines in Children Exposed to Biologic Response Modifiers in Utero","volume":"150","author":"Zerbo","year":"2022","journal-title":"Pediatrics"},{"key":"2026111902151254000_111.12.1112.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2010.05.001"},{"key":"2026111902151254000_111.12.1112.25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/ibd\/izab033","article-title":"Suboptimal Vaccination Administration in Mothers With Inflammatory Bowel Disease and Their Biologic-Exposed Infants","volume":"28","author":"Chiarella-Redfern","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"2026111902151254000_111.12.1112.26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S2352-4642(23)00136-0","article-title":"Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network","volume":"7","author":"Fitzpatrick","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"2026111902151254000_111.12.1112.27","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/14760584.2019.1599286","article-title":"In utero exposure to biologic disease-modifying anti-rheumatic drugs and effects to the infant: infectious complications, vaccine response, and safety of live vaccine administration","volume":"18","author":"Berkhout","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"2026111902151254000_111.12.1112.28","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1093\/rheumatology\/keac141","article-title":"A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic drugs in utero","volume":"61","author":"Goulden","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026111902151254000_111.12.1112.29","doi-asserted-by":"crossref","unstructured":"Kimberlin DW , Banerjee RB , Elizabeth D . Red Book: 20242027 report of the committee on infectious diseases . 2024. Available: https:\/\/publications.aap.org\/redbook\/book\/755\/Red-Book-2024-2027-Report-of-the-Committee-on","DOI":"10.1542\/9781610027373"},{"key":"2026111902151254000_111.12.1112.30","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/apt.15504","article-title":"Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNFa agents: a French nationwide population-based cohort","volume":"50","author":"Luu","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2026111902151254000_111.12.1112.31","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/ibd\/izae220","article-title":"Safety of Rotavirus Vaccination in Infants That Were Exposed to Biologics In Utero: A Systematic Review","volume":"31","author":"Schell","year":"2025","journal-title":"Inflamm Bowel Dis"},{"key":"2026111902151254000_111.12.1112.32","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/cid\/ciy926","article-title":"Understanding the Evolution of Antibiotic-nonsusceptible Pneumococcal Nasopharyngeal Colonization Following Pneumococcal Conjugate Vaccine Implementation in Young Children","volume":"69","author":"Danino","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026111902151254000_111.12.1112.33","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2020.01.034","article-title":"Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis","volume":"38","author":"Muhsen","year":"2020","journal-title":"Vaccine"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2025-329987","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:38:48Z","timestamp":1795095528000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2025-329987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,11,19]]},"published-print":{"date-parts":[[2026,12]]}},"alternative-id":["10.1136\/archdischild-2025-329987"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2025-329987","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}